Exchange: NASDAQ·Updated 04:10 PM EST

BMEA News

News
all
press releases
What's Going On With Biomea Fusion (BMEA) Stock After Hours?
Biomea Fusion reports Phase 1 BMF-650 results, with weight reduction and safety data from its oral GLP-1 drug trial.read more...
Benzinga
What's Going On With Biomea Fusion (BMEA) Stock After Hours?
Biomea Fusion reports Phase 1 BMF-650 results, with weight reduction and safety data from its oral GLP-1 drug trial.read more...
Benzinga
More News
Biomea Fusion shares rise after-hours before Phase I results for oral GLP-1 candidate BMF-650.read more...
Benzinga
Gainers Biomea Fusion (NASDAQ:BMEA) stock increased by 11.0% to $1.51 during Monday's after-market session. The market value of their outstanding shares is at $102.9 million. iTonic Holdings (NASDAQ:ITOC) sharesread more...
Benzinga
From Insulin Management To Cell Replacement: The Diabetes Revolution Is Accelerating   New York, NY – October 7, 2026 – Diabetes cell therapy is moving into a very different phase. For years, the idea of replacing damaged or lost insulin-producing cells sounded more like a long-term scientific goal than a practical treatment strategy. That is […] The post Diabetes Cell Therapy Enters a New Era as Billion-Dollar Market Opportunity Takes Shape appeared first on Financial News Media.
Financial News Media
Biomea Fusion stock falls after ending a public securities offering and revising clinical data timelines for its obesity trial.read more...
Benzinga
Biomea Fusion shares fall nearly 19% after hours, highlighting volatility in BMEA after Tuesday's session.read more...
Benzinga
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Zacks
Here is how Brookdale Senior Living (BKD) and Biomea Fusion, Inc. (BMEA) have performed compared to their sector so far this year.
Zacks
Shares of Biomea Fusion are trading sharply higher on Monday following an operational milestone for its lead metabolic drug program.read more...
Benzinga
Rodman & Renshaw Director of Research Michael King hosted an endocrinology-focused discussion with Dr. Alexander Abitbol, an endocrinologist and assistant medical director at LMC Healthcare, ahead of the American Diabetes Association (ADA) meeting in New Orleans. The conversation centered on tre...
MarketBeat

Advertisement|Remove ads.